No significant differences in gender, age at first diagnosis, KI-67 index, and tumor location, size, and tendency to recur or metastasize were observed with regard to p16-positive (n = 14) and p16-negative (n = 29) chordoma samples (Table 1). This evidence concerns the gene CDKN2A and neoplasm.